Sign in

NCT04430257Active, not recruiting

Pre-exposure Prophylaxis (PrEP) for Health

Efficacy of a Community-based PrEP Uptake Intervention for People Who Inject Drugs (PWID) in the US Northeast

Source: ClinicalTrials.gov · Last updated 13 Oct 2026

Brief summary (registry, in English)

This randomized controlled trial will test the efficacy of "PrEP for Health," a behavioral intervention to improve the use of antiretroviral pre-exposure prophylaxis (PrEP) among at-risk people who inject drugs (PWID) in two syringe service program (SSP) settings in Lawrence and Boston/Cambridge, Massachusetts. The investigators will equally randomize 200 PWID to receive either (a) the "PrEP for Health" intervention condition involving theory-informed HIV and PrEP education, motivational interviewing, problem-solving and planning, and ongoing patient navigation (n=100), or (b) the standard of care condition involving PrEP information and referrals (n=100). Successful PrEP uptake (via medical/pharmacy records), post-treatment PrEP adherence (assessed at 3 months via drug levels in hair), and longer-term PrEP adherence (assessed at 6 and 12 months via drug levels in hair) will be evaluated. The degree to which intervention efficacy occurs through specific conceptual mediators and differs according to hypothesized moderators will also be evaluated.

Status (registry)
Active, not recruiting
Study type
Interventional
Enrollment
200 (estimated)
First submitted
10 Jun 2020
Start date
2 Sept 2021
Primary completion date
16 Jun 2026
Lead sponsor
Brown University
Diseases
HIV
NCT number
NCT04430257

What you commit to

  • Study type: Interventional
  • Planned participants: 200
  • From 2 Sept 2021 to the primary completion date, 16 Jun 2026
  • 2 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Unable to provide informed consent due to severe mental or physical illness, cognitive impairment, or substance intoxication at the time of enrollment

Other

  • Living in Massachusetts (MA) for \<3 months
  • Planning to move out of MA within a year

Who the study is looking for

  • HIV-uninfected (verified by rapid/4th generation test)
  • Reporting past-month injection of any drugs
  • One or more HIV risk behaviors (past-month receptive syringe sharing, transactional sex, or condomless sex with an HIV-infected or unknown-status partner)
  • Not currently on and never taken PrEP
  • Able to understand and speak English or Spanish

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
AIDS Action
Coordinator of this site? Confirm its status
CambridgeUnited StatesUnknown status
Greater Lawrence Family Health Center
Coordinator of this site? Confirm its status
LawrenceUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.